Aarhus University Seal / Aarhus Universitets segl

English

Du er her: AU Om AU  Newsroom Nyheder Vis

Hepatitis/Infectious disease Seminar

Infectious diseases, cancer and treatment of hepatitis – from a drug discovery perspective

06.04.2016 | Anders Esager

Dato tir 03 maj
Tid 13:00 — 16:00
Sted Jeppe Vontillius auditoriet, Aarhus Universitet, Bygning 1252 - Bartholins Allé 3, 8000 Aarhus C
Email Facebook LinkedIn

MSD Denmark and Merck Research Labs will host a seminar focusing on these topics.
The talks will be given by Todd Black, Ernest Asante-Appiah, and Rohit Talwani from Merck Research
labs in the US. They have all played a central role in the development of the treatment of Hepatitis C
for Merck/MSD.

HOW:

Just show up

MORE:

Lunch included hosted by MSD Denmark

AGENDA:

  • 13-13:45
    Overview of current MSD anti-infectives; research activities within hepatitis, anti-bacterial and anti-fungal treatments.
    Todd Black, Exec. Dir., Biology – Discovery, Infectious Diseases
  • 13:45-14:15 Lunch
  • 14:15-15:00
    Development of compounds from a Merck perspective – from idea to testing of the drug, with focus on the methods, analysis, technics and pathways explored
    Ernest Asante-Appiah, Dir., Biology – Discovery, Infectious Diseases
  • 15:00-15:45
    HCV and cancer – HCC and beyond
    Rohit Talwani, Dir., Clinical Research – Late Stage HCV, Infectious Diseases
  • 15:45-16 Open discussion

 

Sincerely

Bent Deleuran
Institute of Biomedicine, Aarhus University
bd@biomed.au.dk

Trine Kallehave
MSD Denmark
trine.kallehave@merck.com

Ph.d.-forsvar, Videnskabelig medarbejder, Institut for Biomedicin, Health, Teknisk/administrativ medarbejder, Offentligheden/Pressen, Ph.d.-studerende

Nyhedsarkiv

Revideret 20.05.2022 - 
Anders Esager